Vicarious Surgical (RBOT) Free Cash Flow Growth (3y) (2023 - 2025)
Vicarious Surgical (RBOT) Free Cash Flow Growth (3y) (2023 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.01 Bn | 175.72 Bn | 6.27 Bn | 6.28% |
| 2 | Stryker | 128.76 Bn | 125.88 Bn | 3.81 Bn | 9.63% |
| 3 | Medtronic | 108.90 Bn | 99.68 Bn | 6.41 Bn | 0.05% |
| 4 | Boston Scientific | 68.43 Bn | 66.98 Bn | 3.61 Bn | 29.36% |
| 5 | Edwards Lifesciences | 47.96 Bn | 44.29 Bn | 1.29 Bn | -27.72% |
| 6 | GE HealthCare Technologies | 28.29 Bn | 26.01 Bn | 1.98 Bn | -29.89% |
| 7 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 77.20% |
| 8 | Smith & Nephew | 26.89 Bn | 26.31 Bn | - | - |
| 9 | Koninklijke Philips | 25.44 Bn | 22.31 Bn | 2.07 Bn | -0.27% |
| 10 | Vicarious Surgical | 625,212.51 | -9.17 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -0.49% |
| Jun 30, 2025 | 4.89% |
| Mar 31, 2025 | 11.22% |
| Dec 31, 2024 | -3.39% |
| Sep 30, 2024 | 2.66% |
| Jun 30, 2024 | -22.73% |
| Mar 31, 2024 | -50.15% |
| Dec 31, 2023 | -220.38% |
| Sep 30, 2023 | -268.49% |